Probiotic Lactobacillus johnsonii RS-7 Alleviates Intestinal Inflammation Via the TLR4/MyD88/NF-κB Signaling Pathway

Puntos clave

• Probiotic Lactobacillus johnsonii RS-7 significantly reduces intestinal inflammation.
• The intervention was shown to activate the TLR4/MyD88/NF-κB signaling pathway.
• Assessment involved laboratory studies focusing on the effects of probiotics on inflammation.
• Support for probiotic use in managing intestinal inflammation is highlighted, emphasizing further clinical exploration.